Brought to you by 
Stentys raises €22.7mm through its initial public offering
27 Apr 2012
Executive Summary
Stentys SA (stents for acute myocardial infarction patients) has raised €22.7mm ($31.9mm) through the initial public offering of 1.9mm shares at €12 each, midway between the company's proposed price range (€10.80-13.20). Stentys' shares will trade on NYSE Euronext Paris.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Stentys raises €22.7mm through its initial public offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice